Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...

Eli Lilly has recently unveiled significant advancements across its product line, including promising results from the BRAVE-AA-PEDS study on adolescents ... to build four new manufacturing ...

US pharma giant Eli Lilly has ventured into India with an anti-obesity and diabetes drug called Mounjaro. This development ...

Cargo was founded by two highly acclaimed cell-therapy researchers. The company raised over $500 million to develop ...

Findings from the Phase 3 BRAVE-AA-PEDS study were presented in a late ... Annual Meeting taking place March New results show Eli Lilly and Company's (NYSE: LLY) EBGLYSS achieved deep and ...

AN ALZHEIMER’S drug hailed as a ‘miracle’ medicine for dementia may cause life-threatening brain bleeds in a third of ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...